Adenocarcinoma Gastric
3 clinical trials · Condition
◉ Watch Adenocarcinoma Gastric
| Record | Firm | Date |
|---|---|---|
| Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer (NCT05071053) | Sanofi | 2021-11-16 |
| DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein (NCT03368196) | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | 2018-04-02 |
| Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma (NCT03409848) | AIO-Studien-gGmbH | 2018-03-01 |
Track Adenocarcinoma Gastric automatically
Every clearance here is in the API, with alerts when new ones post.